Latest / BalVoi:60 Five Eyes Edition
BalVoi:60 | Hourly News Briefing | October 23, 2026 • 11:00 AM EDT
Dr Reddy's Laboratories Reports 36% Decline in Net Profit for Q2 FY27; BioNTech and Gilead Sciences Enter Clinical Trial Agreement to Evaluate Pumitamig Combined with Sacituzumab Govitecan for Triple-Negative Breast Cancer; RBI Bulletin: Indian Economy Shows Strength Amid Global Uncertainty; Russia and Oman Bilateral Trade Reaches 10-Year High at $1.5 Billion; Trump Administration Uses DHS Funds for Television Advertisements Featuring the President; Australia Sanctions Two North Korean Individuals and Two Companies Over Weapons Program Funding; New York City Votes to Ban Horse-Drawn Carriages…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.